[Difluocortolone valerate: a new corticoid for topical use].
The clinical efficacy of diflucortolone valerate as a fatty ointment was investigated in 65 patients with very dry dermatoses. The results were very positive, being excellent in atopic eczema, neurodermatitis and atopic cheilitis. No side effects were observed.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D002613:Cheilitis / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003877:Dermatitis, Contact / Q000188:drug therapy; D004341:Drug Evaluation; D004485:Eczema / Q000188:drug therapy; D005260:Female; D005448:Fluocortolone / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009824:Ointments; D011244:Pregnadienediols / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D014631:Valerates / Q000627:therapeutic use
D009824:Ointments; D011244:Pregnadienediols; D014631:Valerates; D005448:Fluocortolone
Diflucortolonvalerianat: Ein neues Kortikoid zur topischen Anwendung